Browse by UCL Departments and Centres
Group by: Author | Type
Number of items: 172.
A
Abu-Hanna, J;
Taanman, J-W;
Abraham, D;
Clapp, L;
(2018)
Impact of treprostinil on dynamin-related protein 1 (DRP1) and mitochondrial fragmentation in pulmonary arterial hypertension (PAH).
[Lecture].
Presented at: 28th International Congress of the European-Respiratory-Society (ERS), Paris, FRANCE.
|
Adams, D;
Gonzalez-Duarte, A;
O'Riordan, WD;
Yang, C-C;
Ueda, M;
Kristen, AV;
Tournev, I;
... Suhr, OB; + view all
(2018)
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.
The New England Journal of Medicine
, 379
(1)
pp. 11-21.
10.1056/NEJMoa1716153.
|
Adams, D;
Hawkins, PN;
Polydefkis, M;
(2018)
Oligonucleotide Drugs for Transthyretin Amyloidosis.
New England Journal of Medicine
, 379
(21)
p. 2086.
10.1056/NEJMc1810994.
|
Adler, S;
Huscher, D;
Siegert, E;
Allanore, Y;
Czirják, L;
DelGaldo, F;
Denton, CP;
... EUSTAR co-workers on behalf of the DeSScipher project research g; + view all
(2018)
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.
Arthritis Research & Therapy
, 20
(1)
, Article 17. 10.1186/s13075-018-1517-z.
|
Adriani, M;
Nytrova, P;
Mbogning, C;
Hässler, S;
Medek, K;
Jensen, PEH;
CREEKE, P;
... The ABIRISK Consortium; + view all
(2018)
Monocyte NOTCH2 expression predicts interferon-beta immunogenicity in multiple sclerosis patients.
JCI Insight
, 3
(11)
, Article e99274. 10.1172/jci.insight.99274.
|
Aimo, A;
Buda, G;
Fontana, M;
Barison, A;
Vergaro, G;
Emdin, M;
Merlini, G;
(2018)
Therapies for cardiac light chain amyloidosis: An update.
International Journal of Cardiology
, 271
pp. 152-160.
10.1016/j.ijcard.2018.05.018.
|
Alani, H;
Henty, J;
Thompson, N;
Jury, E;
Ciurtin, C;
(2018)
Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren’s syndrome (secondary Sjögren’s syndrome) focusing on autoimmune rheumatic diseases.
Scandinavian Journal of Rheumatology
, 47
(2)
pp. 141-154.
10.1080/03009742.2017.1324909.
|
Alexandre, AR;
Carreira, PL;
Isenberg, DA;
(2018)
Very delayed lupus nephritis: a report of three cases and literature review.
Lupus Sci Med
, 5
(1)
, Article e000241. 10.1136/lupus-2017-000241.
|
Allanore, Y;
Distler, O;
Jagerschmidt, A;
Illiano, S;
Ledein, L;
Boitier, E;
Agueusop, I;
... Khanna, D; + view all
(2018)
Double-blind, Randomized, 8-week Placebo-controlled followed by a 16-week open label extension study, with the LPA1 receptor antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis.
Arthritis Rheumatology
, 70
(10)
pp. 1634-1643.
10.1002/art.40547.
|
Allanore, Y;
Distler, O;
Matucci-Cerinic, M;
Denton, CP;
(2018)
Review: Defining a Unified Vascular Phenotype in Systemic Sclerosis.
Arthritis & Rheumatology
, 70
(2)
pp. 162-170.
10.1002/art.40377.
|
Alyousef, AA;
Nihtyanova, S;
Denton, C;
Bosoni, P;
Bellazzi, R;
Tucker, A;
(2018)
Nearest Consensus Clustering Classification to Identify Subclasses and Predict Disease.
Journal of Healthcare Informatics Research
, 2
(4)
pp. 402-422.
10.1007/s41666-018-0029-6.
|
Arbore, G;
West, EE;
Rahman, J;
Le Friec, G;
Niyonzima, N;
Pirooznia, M;
Tunc, I;
... Kemper, C; + view all
(2018)
Complement receptor CD46 co-stimulates optimal human CD8(+) T cell effector function via fatty acid metabolism.
Nature Communications
, 9
, Article 4186. 10.1038/s41467-018-06706-z.
|
Aringer, M;
Denton, CP;
(2018)
Systemic sclerosis phase III clinical trials: Hope on the horizon?
Journal of Scleroderma and Related Disorders
, 3
(3)
pp. 193-200.
10.1177/2397198318775353.
|
Arnold, MB;
Khanna, D;
Denton, CP;
van Laar, JM;
Frech, TM;
Anderson, ME;
Baron, M;
... Pope, JE; + view all
(2018)
Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis.
Rheumatology
, 57
(1)
pp. 152-157.
10.1093/rheumatology/kex396.
|
Ashaye, T;
Hounsome, N;
Carnes, D;
Taylor, SJC;
Homer, K;
Eldridge, S;
Spencer, A;
... COPERS Study Team (ISRCTN 24426731); + view all
(2018)
Opioid prescribing for chronic musculoskeletal pain in UK primary care: results from a cohort analysis of the COPERS trial.
BMJ Open
, 8
(6)
, Article e019491. 10.1136/bmjopen-2017-019491.
|
B
Bageghni, SA;
Hemmings, KE;
Zava, N;
Denton, CP;
Porter, KE;
Ainscough, JFX;
Drinkhill, MJ;
(2018)
Cardiac fibroblast-specific p38α MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism.
FASEB Journal
, 32
(9)
pp. 4941-4954.
10.1096/fj.201701455RR.
|
Bakshi, J;
Segura, BT;
Wincup, C;
Rahman, A;
(2018)
Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus.
Clinical Reviews in Allergy & Immunology
, 55
(3)
pp. 352-367.
10.1007/s12016-017-8640-5.
|
Barber, MRW;
Hanly, JG;
Su, L;
Urowitz, MB;
Pierre, YS;
Romero-Diaz, J;
Gordon, C;
... Clarke, AE; + view all
(2018)
Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach.
Arthritis Care & Research
, 70
(9)
pp. 1294-1302.
10.1002/acr.23480.
|
Ben-Chetrit, E;
Gattorno, M;
Gul, A;
Kastner, DL;
Lachmann, HJ;
Touitou, I;
Ruperto, N;
(2018)
Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study.
Annals of the Rheumatic Diseases
, 77
(11)
pp. 1558-1565.
10.1136/annrheumdis-2017-212515.
|
Bernatsky, S;
Ramsey-Goldman, R;
Petri, M;
Urowitz, MB;
Gladman, DD;
Fortin, PR;
Yelin, EH;
... Clarke, AE; + view all
(2018)
Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus.
The Journal of Rheumatology
, 45
(3)
pp. 393-396.
10.3899/jrheum.170652.
|
Borthwick, NJ;
Lane, T;
Moyo, N;
Crook, A;
Shim, JM;
Baines, I;
Wee, EG;
... Pepys, MB; + view all
(2018)
Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.
PLOS ONE
, 13
(5)
, Article e0197299. 10.1371/journal.pone.0197299.
|
Boyle, EM;
Ashby, C;
Wardell, CP;
Rowczenio, D;
Sachchithanantham, S;
Wang, Y;
Johnson, SK;
... Wechalekar, AD; + view all
(2018)
The genomic landscape of plasma cells in systemic light chain amyloidosis.
Blood
, 132
(26)
pp. 2775-2777.
10.1182/blood-2018-08-872226.
|
Brancolini, G;
Maschio, MC;
Cantarutti, C;
Corazza, A;
Fogolari, F;
Bellotti, V;
Corni, S;
(2018)
Citrate stabilized gold nanoparticles interfere with amyloid fibril formation: D76N and Delta N6 beta 2-microglobulin variants.
Nanoscale
, 10
(10)
pp. 4793-4806.
10.1039/c7nr06808e.
|
Bray, T;
Dudek, A;
Sakai, N;
Rajesparan, K;
Fisher, C;
Ciurtin, C;
Sen, D;
... Hall-Craggs, M; + view all
(2018)
The bench tool: quantitative MRI-based method for measuring oedema and fat metaplasia in spondyloarthrititis.
Presented at: Annual European Congress of Rheumatology - European League Against Rheumatism (EULAR) 2018, Amsterdam, Netherlands.
(In press).
|
Brito-Zerón, P;
Acar-Denizli, N;
Ng, W-F;
Zeher, M;
Rasmussen, A;
Mandl, T;
Seror, R;
... Sjögren Big Data Consortium; + view all
(2018)
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).
Clinical and Experimental Rheumatology
, S36
(112(3))
pp. 102-112.
|
Buckley, CD;
Gordon, C;
Isenberg, D;
Snaith, M;
Scott, DGI;
Luqmani, R;
Moots, R;
... Raza, K; + view all
(2018)
Obituary for Paul Bacon.
Rheumatology
, 57
(5)
pp. 943-945.
10.1093/rheumatology/key030.
|
Bystrom, J;
Clanchy, FI;
Taher, TE;
Al-Bogami, M;
Ong, VH;
Abraham, DJ;
Williams, RO;
(2018)
Functional and phenotypic heterogeneity of Th17 cells in health and disease.
European Journal of Clinical Investigation
, Article e13032. 10.1111/eci.13032.
(In press).
|
C
Caetano, J;
Nihtyanova, SI;
Harvey, J;
Denton, CP;
Ong, VH;
(2018)
Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis.
Rheumatology Advances in Practice
, 2
(1)
, Article rky002. 10.1093/rap/rky002.
|
Campochiaro, C;
Host, LV;
Ong, VH;
Denton, CP;
(2018)
Development of systemic sclerosis in transgender females: a case series and review of the literature.
Clinical and Experimental Rheumatology
(In press).
|
Cantarutti, C;
Bertoncin, P;
Posocco, P;
Hunashal, Y;
Giorgetti, S;
Bellotti, V;
Fogolari, F;
(2018)
The interaction of β2-microglobulin with gold nanoparticles: impact of coating, charge and size.
Journal of Materials Chemistry B
, 6
(37)
pp. 5964-5974.
10.1039/c8tb01129j.
|
Cantarutti, C;
Raj, G;
Fogolari, F;
Giorgetti, S;
Corazza, A;
Bellotti, V;
Naumov, P;
(2018)
Interference of citrate-stabilized gold nanoparticles with β2-microglobulin oligomeric association.
Chemical Communication
, 54
(43)
pp. 5422-5425.
10.1039/c8cc01053f.
|
Carrier, ME;
Kwakkenbos, L;
Boutron, I;
Welling, J;
Sauve, M;
van den Ende, C;
Schouffoer, AA;
... Manning, J; + view all
(2018)
Randomized feasibility trial of the Scleroderma patient-centered intervention network hand exercise program (SPIN-HAND): Study protocol.
Journal of Scleroderma and Related Disorders
, 3
(1)
pp. 91-97.
10.5301/jsrd.5000263.
|
Chaigne, B;
Clary, G;
Le Gall, M;
Dumoitier, N;
Fernandez, C;
Lofek, S;
Chafey, P;
... Mouthon, L; + view all
(2018)
Proteomic Analysis of Human Scleroderma Fibroblasts Response to Transforming Growth Factor-ß.
Proteomics Clinical Applications
, Article e1800069. 10.1002/prca.201800069.
|
Chapman, MA;
Sive, J;
Ambrose, J;
Roddie, C;
Counsell, N;
Lach, A;
Abbasian, M;
... Yong, K; + view all
(2018)
RNA-Seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.
Blood
, 132
(20)
pp. 2154-2165.
10.1182/blood-2018-05-849893.
|
Ciurtin, C;
(2018)
Biology of the adolescent immune system.
Presented at: UCL Centre of Adolescent Rheumatology International advisory meeting, London, UK.
|
Ciurtin, C;
(2018)
Seronegative spondyloarthropathies – case studies (British Society of Rheumatology Ultrasound Course).
[Scholarly edition].
British Society of Rheumatology
|
Ciurtin, C;
(2018)
Ultrasound in established rheumatoid arthritis (British Society of Rheumatology Course).
[Scholarly edition].
British Society of Rheumatology
|
Clark, KEN;
Giles, I;
(2018)
Antiphospholipid syndrome.
Medicine
, 46
(2)
pp. 118-125.
10.1016/j.mpmed.2017.11.006.
|
Clark, KEN;
Isenberg, DA;
(2018)
A review of inflammatory idiopathic myopathy focusing on polymyositis.
European Journal of Neurology
, 25
(1)
pp. 13-23.
10.1111/ene.13357.
|
Coghlan, G;
Wolf, M;
Distler, O;
Denton, CP;
Doelberg, M;
Harutyunova, S;
Marra, AM;
... Grünig, E; + view all
(2018)
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis.
European Respiratory Journal
, 51
(3)
10.1183/13993003.01197-2017.
|
Coghlan, JG;
Denton, CP;
(2018)
Aggressive combination therapy for treatment of systemic sclerosis-associated pulmonary hypertension.
Journal of Scleroderma and Related Disorders
, 3
(1)
pp. 30-38.
10.1177/2397198318758422.
|
Cohen, H;
Efthymiou, M;
Gates, C;
Isenberg, D;
(2018)
Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome.
Seminars in Thrombosis and Hemostasis
, 44
(05)
pp. 427-438.
10.1055/s-0036-1597902.
|
Cohen, H;
Efthymiou, M;
Isenberg, DA;
(2018)
Use of direct oral anticoagulants in antiphospholipid syndrome.
Journal of Thrombosis and Haemostasis
, 16
(6)
pp. 1028-1039.
10.1111/jth.14017.
|
Cope, AP;
Barnes, MR;
Belson, A;
Binks, M;
Brockbank, S;
Bonachela-Capdevila, F;
Carini, C;
... RA-MAP Consortium; + view all
(2018)
The RA-MAP Consortium: a working model for academia-industry collaboration.
Nature Reviews Rheumatology
, 14
(1)
pp. 53-60.
10.1038/nrrheum.2017.200.
|
Cornelius, V;
Wilson, R;
Cro, S;
Barker, J;
Burden, D;
Griffiths, CEM;
Lachmann, H;
... Smith, C; + view all
(2018)
A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial.
Trials
, 19
(465)
10.1186/s13063-018-2841-y.
|
D
De Benedetti, F;
Gattorno, M;
Anton, J;
Ben-Chetrit, E;
Frenkel, J;
Hoffman, HM;
Koné-Paut, I;
... Junge, G; + view all
(2018)
Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
The New England Journal of Medicine
, 378
(20)
pp. 1908-1919.
10.1056/NEJMoa1706314.
|
Denton, CP;
Herrick, AL;
(2018)
Reply [Pauling, et al., Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis].
Arthritis & Rheumatology
, 70
(6)
p. 974.
10.1002/art.40480.
|
Denton, CP;
Ong, VH;
Xu, S;
Chen-Harris, H;
Modrusan, Z;
Lafyatis, R;
Khanna, D;
... Sornasse, T; + view all
(2018)
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
Annals of the Rheumatic Diseases
10.1136/annrheumdis-2018-213031.
(In press).
|
Denton, CP;
Wells, AU;
Coghlan, JG;
(2018)
Major lung complications of systemic sclerosis (vol 14, pg 511, 2018).
[Corrigendum].
Nature Reviews Rheumatology
, 14
(11)
p. 682.
10.1038/s41584-018-0108-3.
|
Denton, CP;
Wells, AU;
Coghlan, JG;
(2018)
Major lung complications of systemic sclerosis.
Nature Reviews Rheumatology
, 14
pp. 511-527.
10.1038/s41584-018-0062-0.
|
Dhaliwal, K;
Griffin, M;
Denton, CP;
Butler, PEM;
(2018)
The novel use of botulinum toxin A for the treatment of Raynaud's phenomenon in the toes.
BMJ Case Reports
, 2018
, Article bcr-2017-219348. 10.1136/bcr-2017-219348.
|
Distler, O;
Allanore, Y;
Denton, CP;
Matucci-Cerinic, M;
Pope, JE;
Hinzmann, B;
Davies, S;
... Khanna, D; + view all
(2018)
Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis.
Rheumatology
, 57
(5)
pp. 813-817.
10.1093/rheumatology/kex504.
|
Dougherty, DH;
Kwakkenbos, L;
Carrier, M-E;
Salazar, G;
Assassi, S;
Baron, M;
Bartlett, SJ;
... SPIN Investigators; + view all
(2018)
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts.
Rheumatology
, 57
(9)
pp. 1623-1631.
10.1093/rheumatology/key139.
|
Dritsoula, A;
Papaioannou, I;
Guerra, SG;
Fonseca, C;
Martin, J;
Herrick, AL;
Abraham, DJ;
... Ponticos, M; + view all
(2018)
The molecular basis for dysregulated activation of NKX2-5 in vascular remodelling of systemic sclerosis.
Arthritis & Rheumatology
, 70
(6)
pp. 920-931.
10.1002/art.40419.
|
Dumusc, A;
Ng, W-F;
James, K;
Griffiths, B;
Price, E;
Pease, C;
Emery, P;
... Bowman, S; + view all
(2018)
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry.
Swiss Medical Weekly
, 148
, Article w14588. 10.4414/smw.2018.14588.
|
E
Elliott, C;
Rojo, A;
Ribe, E;
Broadstock, M;
Xia, W;
Morin, P;
Semenov, M;
... Killick, R; + view all
(2018)
A role for APP in Wnt signalling links synapse loss with β-amyloid production.
Translational Psychiatry
, 8
, Article 179. 10.1038/s41398-018-0231-6.
|
Ezeonyeji, Amara N;
(2018)
Expression and regulation of Th-17, Th-1 and Th-22 cells in psoriatic arthritis.
Doctoral thesis (M.D(Res)), UCL (University College London).
|
F
Federici, S;
Vanoni, F;
Ben-Chetrit, E;
Cantarini, L;
Frenkel, J;
Goldbach-Mansky, R;
Gul, A;
... Pediatric Rheumatology International Trials Organization(PRINTO), .; + view all
(2018)
An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor-associated Periodic Fever Syndromes, and Cryopyrin-associated Periodic Syndrome.
The Journal of Rheumatology
, 45
(11)
, Article jrheum.180056. 10.3899/jrheum.180056.
|
Fox, TA;
Lunn, M;
Wechalekar, A;
Bomanji, J;
Wan, S;
D'Sa, S;
(2018)
[18F]Florbetaben PET-CT confirms AL amyloidosis in a patient with Waldenström's Macroglobulinaemia.
Haematologica
, 103
(6)
10.3324/haematol.2017.184515.
|
G
Gage, MC;
Bécares, N;
Louie, R;
Waddington, KE;
Zhang, Y;
Tittanegro, TH;
Rodríguez-Lorenzo, S;
... Pineda-Torra, I; + view all
(2018)
Disrupting LXRα phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation.
Proceedings of the National Academy of Sciences of the United States of America
, 115
(28)
E6556-E6565.
10.1073/pnas.1721245115.
|
Garaud, S;
Taher, TE;
Debant, M;
Burgos, M;
Melayah, S;
Berthou, C;
Parikh, K;
... Mageed, RA; + view all
(2018)
CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.
Cellular & Molecular Immunology
, 15
(2)
pp. 158-170.
10.1038/cmi.2016.42.
|
Gholizadeh, S;
Kwakkenbos, L;
Carrier, ME;
Mills, SD;
Fox, RS;
Jewett, LR;
Gottesman, K;
... Persmann, J; + view all
(2018)
Validation of the social interaction anxiety scale in scleroderma: A scleroderma patientcentered intervention network cohort study.
Journal of Scleroderma and Related Disorders
, 3
(1)
pp. 98-105.
10.5301/jsrd.5000264.
|
Gilbert, RM;
Zhang, X;
Sampson, RD;
Ehrenstein, MR;
Nguyen, DX;
Chaudhry, M;
Mein, C;
... Lightman, S; + view all
(2018)
Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.
Frontiers in Immunology
, 9
, Article 907. 10.3389/fimmu.2018.00907.
|
Giles, I;
Salama, AD;
(2018)
The autoimmune rheumatic diseases – an introduction.
Medicine
, 46
(2)
p. 77.
10.1016/j.mpmed.2017.11.009.
|
Gillespie, J;
Ross, RL;
Corinaldesi, C;
Esteves, F;
Derrett-Smith, E;
McDermott, MF;
Doody, GM;
... Del Galdo, F; + view all
(2018)
TGFβ activation primes canonical Wnt signaling through the downregulation of AXIN2.
Arthritis & Rheumatology
, 70
(6)
pp. 932-942.
10.1002/art.40437.
|
Gillmore, JD;
Damy, T;
Fontana, M;
Hutchinson, M;
Lachmann, HJ;
Martinez-Naharro, A;
Quarta, CC;
... Hawkins, PN; + view all
(2018)
A new staging system for cardiac transthyretin amyloidosis.
European Heart Journal
, 39
(30)
pp. 2799-2806.
10.1093/eurheartj/ehx589.
|
González-Serna, D;
Carmona, EG;
Ortego-Centeno, N;
Simeón, CP;
Solans, R;
Hernández-Rodríguez, J;
Tolosa, C;
... Márquez, A; + view all
(2018)
A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility.
PLOS ONE
, 13
(12)
, Article e0209343. 10.1371/journal.pone.0209343.
|
Gordon, C;
Amissah-Arthur, M-B;
Gayed, M;
Brown, S;
Bruce, IN;
D'Cruz, D;
Empson, B;
... Isenberg, D; + view all
(2018)
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults.
Rheumatology
, 57
(1)
E1-E45.
10.1093/rheumatology/kex286.
|
Gordon, C;
Amissah-Arthur, M-B;
Gayed, M;
Brown, S;
Bruce, IN;
D'Cruz, D;
Empson, B;
... British Society for Rheumatology Standards, Audit and Guidelines, .; + view all
(2018)
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary.
Rheumatology
, 57
(1)
pp. 14-18.
10.1093/rheumatology/kex291.
|
Gordon, C;
Amissah-Arthur, M-B;
Gayed, M;
Brown, S;
Bruce, IN;
D'Cruz, D;
Empson, B;
... British Society for Rheumatology Standards, Audit and Guidelines, .; + view all
(2018)
Comment on: The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: reply.
Rheumatology
, 57
(8)
pp. 1502-1503.
10.1093/rheumatology/key170.
|
Gyftaki-Venieri, DA;
Abraham, DJ;
Ponticos, S;
(2018)
Insights into myofibroblasts and their activation in scleroderma: opportunities for therapy?
Current Opinion in Rheumatology
, 30
(6)
pp. 581-587.
10.1097/BOR.0000000000000543.
|
H
Hanly, JG;
Li, Q;
Su, L;
Urowitz, MB;
Gordon, C;
Bae, S-C;
Romero-Diaz, J;
... Farewell, V; + view all
(2018)
Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
Arthritis Care & Research
, 70
(10)
pp. 1478-1487.
10.1002/acr.23509.
|
Herrick, AL;
Peytrignet, S;
Lunt, M;
Pan, X;
Hesselstrand, R;
Mouthon, L;
Silman, AJ;
... Denton, CP; + view all
(2018)
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.
Annals of the Rheumatic Diseases
, 77
(4)
pp. 563-570.
10.1136/annrheumdis-2017-211912.
|
Hong, Y;
Standing, ASI;
Nanthapisal, S;
Sebire, N;
Jolles, S;
Omoyinmi, E;
Verstegen, RH;
... Eleftheriou, D; + view all
(2018)
Autoinflammation due to homozygous S208 MEFV mutation.
Annals of the Rheumatic Diseases
, 78
(4)
pp. 571-573.
10.1136/annrheumdis-2018-214102.
|
Hsu, VM;
Denton, CP;
Domsic, RT;
Furst, DE;
Rischmueller, M;
Stanislav, M;
Steen, VD;
... Hough, DR; + view all
(2018)
Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study.
The Journal of Rheumatology
, 45
(3)
pp. 405-410.
10.3899/jrheum.161040.
|
Hughes, M;
Murray, A;
Denton, CP;
Herrick, AL;
(2018)
Should all digital ulcers be included in future clinical trials of systemic sclerosis-related digital vasculopathy?
Medical Hypotheses
, 116
pp. 101-104.
10.1016/j.mehy.2018.04.024.
|
Hughes, M;
Tracey, A;
Bhushan, M;
Chakravarty, K;
Denton, CP;
Dubey, S;
Guiducci, S;
... Herrick, AL; + view all
(2018)
Reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: A challenge for clinical trial design.
Journal of Scleroderma and Related Disorders
, 3
(2)
pp. 170-174.
10.1177/2397198318764796.
|
I
Isenberg, D;
Sturgess, J;
Allen, E;
Aranow, C;
Askanase, A;
Sang-Cheol, B;
Bernatsky, S;
... Gordon, C; + view all
(2018)
Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients.
Arthritis Care and Research
, 70
(1)
pp. 98-103.
10.1002/acr.23252.
|
Isenberg, DA;
Rahman, A;
(2018)
Rheumatology: Introduction.
Medicine
, 46
(3)
p. 151.
10.1016/j.mpmed.2017.12.006.
|
J
Jaeger, VK;
Valentini, G;
Hachulla, E;
Cozzi, F;
Distler, O;
Airó, P;
Czirják, L;
... EUSTAR co-authors; + view all
(2018)
Smoking in Systemic Sclerosis: a Longitudinal European Scleroderma Trials and Research Group Study.
Arthritis & Rheumatology
, 70
(11)
pp. 1829-1834.
10.1002/art.40557.
|
Jaffer, S;
Goh, P;
Abbasian, M;
Nathwani, AC;
(2018)
Mbd3 Promotes Reprogramming of Primary Human Fibroblasts.
International Journal of Stem Cells
, 11
(2)
pp. 235-241.
10.15283/ijsc18036.
|
James, K;
Chipeta, C;
Parker, A;
Harding, S;
Cockell, SJ;
Gillespie, CS;
Hallinan, J;
... Mewar, D; + view all
(2018)
B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome.
Rheumatology
, 57
(7)
pp. 1222-1227.
10.1093/rheumatology/key063.
|
Jeyaratnam, J;
Ter Haar, NM;
Lachmann, HJ;
Kasapcopur, O;
Ombrello, AK;
Rigante, D;
Dedeoglu, F;
... Frenkel, J; + view all
(2018)
The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey.
Pediatr Rheumatol Online J
, 16
, Article 19. 10.1186/s12969-018-0235-z.
|
Johnson, SR;
Soowamber, ML;
Fransen, J;
Khanna, D;
Van den Hoogen, F;
Baron, M;
Matucci-Cerinic, M;
... Pope, JE; + view all
(2018)
There is a need for new systemic sclerosis subset criteria. A content analytic approach.
Scandinavian Journal of Rheumatology
, 47
(1)
pp. 62-70.
10.1080/03009742.2017.1299793.
|
Jones, A;
Ciurtin, C;
Ismajli, M;
Leandro, M;
Sengupta, R;
Machado, PM;
(2018)
Biologics for treating axial spondyloarthritis.
Expert Opinion on Biological Therapy
, 18
(6)
pp. 641-652.
10.1080/14712598.2018.1468884.
|
Jones, A;
Cotton, A;
Guinto, J;
Wilton, J;
Ciurtin, C;
(2018)
Outcome measures of disease activity for rare autoimmune rheumatic diseases.
British Journal of Hospital Medicine
, 79
(7)
pp. 396-401.
10.12968/hmed.2018.79.7.396.
|
K
Keddie, S;
Parker, T;
Lachmann, HJ;
Ginsberg, L;
(2018)
Cryopyrin-Associated Periodic Fever Syndrome and the Nervous System.
Current Treatment Options in Neurology
, 20
(10)
, Article 43. 10.1007/s11940-018-0526-1.
|
Khanna, D;
Denton, CP;
Lin, CJ;
van Laar, JM;
Frech, TM;
Anderson, ME;
Baron, M;
... Furst, DE; + view all
(2018)
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate).
Annals of the Rheumatic Diseases
, 77
pp. 212-220.
10.1136/annrheumdis-2017-211682.
|
Khanna, D;
Tashkin, DP;
Denton, CP;
Lubell, MW;
Vazquez-Mateo, C;
Wax, S;
(2018)
Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung disease.
Rheumatology
10.1093/rheumatology/key151.
(In press).
|
King, J;
Abraham, D;
Stratton, R;
(2018)
Chemokines in systemic sclerosis.
[Review].
Immunology Letters
, 195
pp. 68-75.
10.1016/j.imlet.2017.12.001.
|
Kotecha, T;
Martinez-Naharro, A;
Treibel, TA;
Francis, R;
Nordin, S;
Abdel-Gadir, A;
Knight, DS;
... Fontana, M; + view all
(2018)
Myocardial Edema and Prognosis in Amyloidosis.
Journal of the American College of Cardiology
, 71
(25)
pp. 2919-2931.
10.1016/j.jacc.2018.03.536.
|
L
Le Marchand, T;
de Rosa, M;
Salvi, N;
Sala, BM;
Andreas, LB;
Barbet-Massin, E;
Sormanni, P;
... Ricagno, S; + view all
(2018)
Conformational dynamics in crystals reveal the molecular bases for D76N beta-2 microglobulin aggregation propensity.
Nature Communications
, 9
, Article 1658. 10.1038/s41467-018-04078-y.
|
Lei, L;
Morgan, S;
Ciurtin, C;
(2018)
PS6:120 Hand ultrasound guided therapeutic decisions in inflammatory arthritis associated with systemic lupus erythematosus and Sjögren's syndrome.
Presented at: 11th European Lupus Meeting, Düsseldorf, Germany.
|
Lei, L;
Morgan, S;
Ntatsaki, E;
Ciurtin, C;
(2018)
Hand ultrasound guided therapeutic decisions in inflammatory arthritis associated with Systemic Lupus Erythematosus and Sjögrens syndrome.
Presented at: 11. European Lupus Meeting, Düsseldorf, Germany.
|
Leri, M;
Oropesa-Nuñez, R;
Canale, C;
Raimondi, S;
Giorgetti, S;
Bruzzone, E;
Bellotti, V;
... Bucciantini, M; + view all
(2018)
Oleuropein aglycone: A polyphenol with different targets against amyloid toxicity.
Biochimica et Biophysica Acta (BBA) - General Subjects
, 1862
(6)
pp. 1432-1442.
10.1016/j.bbagen.2018.03.023.
|
Levinson, G;
Ahmed, U;
Ciurtin, C;
(2018)
Factors associated with oral specialist referral of patients with Sjögren’s syndrome in a rheumatology tertiary centre.
Presented at: British Society for Rheumatology Annual Conference 2018, Liverpool, UK.
|
Lilleker, JB;
Vencovsky, J;
Wang, G;
Wedderburn, LR;
Diederichsen, LP;
Schmidt, J;
Oakley, P;
... all EuroMyositis contributors; + view all
(2018)
The EuroMyositis registry: an international collaborative tool to facilitate myositis research.
Annals of the Rheumatic Diseases
, 77
(1)
pp. 30-39.
10.1136/annrheumdis-2017-211868.
|
Little, J;
Parker, B;
Lunt, M;
Hanly, JG;
Urowitz, MB;
Clarke, AE;
Romero-Diaz, J;
... Bruce, IN; + view all
(2018)
Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort.
Rheumatology
, 57
(4)
pp. 677-687.
10.1093/rheumatology/kex444.
|
M
Magill, L;
Adriani, M;
Berthou, V;
Chen, K;
Gleizes, A;
Hacein-Bey-Abina, S;
Hincelin-Mery, A;
... Mauri, C; + view all
(2018)
Low Percentage of Signal Regulatory Protein alpha/beta(+) Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis Patients.
Frontiers in Immunology
, 9
, Article 2865. 10.3389/fimmu.2018.02865.
|
Mangione, PP;
Verona, G;
Corazza, A;
Marcoux, J;
Canetti, D;
Giorgetti, S;
Raimondi, S;
... Bellotti, V; + view all
(2018)
Plasminogen activation triggers transthyretin amyloidogenesis in vitro.
Journal of Biological Chemistry
, 293
(37)
pp. 14192-14199.
10.1074/jbc.RA118.003990.
|
Manwani, R;
Foard, D;
Mahmood, S;
Sachchithanantham, S;
Lane, T;
Quarta, C;
Youngstein, T;
... Wechalekar, AD; + view all
(2018)
Rapid Hematologic Responses Improve Outcomes In Patients With Very Advanced (Stage IIIb) Cardiac Immunoglobulin Light Chain Amyloidosis.
Haematologica
, 103
(4)
e165-e168.
10.3324/haematol.2017.178095.
|
Manwani, R;
Hegenbart, U;
Mahmood, S;
Sachchithanantham, S;
Kyriakou, C;
Yong, K;
Popat, R;
... Wechalekar, A; + view all
(2018)
Deferred autologous stem cell transplantation in systemic AL amyloidosis.
Blood Cancer Journal
, 8
, Article 101. 10.1038/s41408-018-0137-9.
|
Manwani, R;
Page, J;
Lane, T;
Burniston, M;
Skillen, A;
Lachmann, HJ;
Gillmore, JD;
... Wechalekar, AD; + view all
(2018)
A pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement.
Amyloid. The Journal of Protein Folding Disorders
, 25
(4)
pp. 247-252.
10.1080/13506129.2018.1552852.
|
Manwani, R;
Sachchithanantham, S;
Mahmood, S;
Foard, D;
Sharpley, F;
Rezk, T;
Lane, T;
... Wechalekar, AD; + view all
(2018)
Treatment of IgM-associated immunoglobulin light chain amyloidosis with Rituximab-Bendamustine.
Blood
10.1182/blood-2018-04-846493.
(In press).
|
Manwani, R;
Wrench, D;
Wechalekar, A;
Lachmann, H;
(2018)
Successful treatment of systemic AA amyloidosis associated with underlying Hodgkin lymphoma.
British Journal of Haematology
, 182
(5)
p. 619.
10.1111/bjh.15269.
|
Martinez-Naharro, A;
Abdel-Gadir, A;
Treibel, TA;
Zumbo, G;
Knight, DS;
Rosmini, S;
Lane, T;
... Fontana, M; + view all
(2018)
CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy.
[Letter].
JACC: Cardiovascular Imaging
, 11
(1)
pp. 152-154.
10.1016/j.jcmg.2017.02.012.
|
Martinez-Naharro, A;
Hawkins, PN;
Fontana, M;
(2018)
Cardiac amyloidosis.
Clinical Medicine
, 18
(Suppl 2)
s30-s35.
10.7861/clinmedicine.18-2-s30.
|
Martinez-Naharro, A;
Kotecha, T;
Norrington, K;
Boldrini, M;
Rezk, T;
Quarta, C;
Treibel, TA;
... Fontana, M; + view all
(2018)
Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
JACC: Cardiovascular Imaging
10.1016/j.jcmg.2018.02.006.
(In press).
|
Martinez-Naharrro, A;
Kotecha, T;
Baggiano, A;
Boldrini, M;
Rezk, T;
Knight, DS;
Manwani, R;
... Fontana, M; + view all
(2018)
Assessment of Treatment Response in Cardiac AL Amyloidosis Using CMR Mapping - Results at 3 Months, 6 Months and 1 Year Post-Chemotherapy.
Presented at: Imaging and Nuclear Medicine, Session Title: Melvin Judkins Young Investigator Competition.
|
McCarthy, EM;
Sutton, E;
Nesbit, S;
White, J;
Parker, B;
Jayne, D;
Griffiths, B;
... British Isles Lupus Assessment Group Biologics Register, BILAGBR; + view all
(2018)
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.
Rheumatology
, 57
(3)
pp. 470-479.
10.1093/rheumatology/kex395.
|
McDonnell, T;
Artim-Esen, B;
Wincup, C;
Ripoll, VM;
Isenberg, D;
Giles, IP;
Rahman, A;
(2018)
Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I.
Frontiers in Immunology
, 9
(2224)
10.3389/fimmu.2018.02244.
|
McDonnell, T;
Bradford, C;
Raj, D;
Ciurtin, C;
Jury, E;
Manson, J;
(2018)
Differential activation of complement in rheumatoid arthritis.
Presented at: Annual European Congress of Rheumatology - European League Against Rheumatism (EULAR) - 2018, Amsterdam, Netherlands.
|
McDonnell, TCR;
Willis, R;
Pericleous, C;
Ripoll, VM;
Giles, IP;
Isenberg, DA;
Brasier, AR;
... Rahman, A; + view all
(2018)
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome.
Frontiers in Immunology
, 9
, Article 2413. 10.3389/fimmu.2018.02413.
|
McDonnell, TCR;
Wincup, C;
Rahman, A;
Giles, I;
(2018)
Going viral in rheumatology: Using social media to show that mechanistic research is relevant to patients with lupus and antiphospholipid syndrome.
Rheumatology Advances in Practice
, 2
(1)
, Article rky003. 10.1093/rap/rky003.
|
Mensah, FFK;
Armstrong, CW;
Reddy, V;
Bansal, AS;
Berkovitz, S;
Leandro, MJ;
Cambridge, G;
(2018)
CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Frontiers in Immunology
, 9
, Article 242. 10.3389/fimmu.2018.02421.
|
Merlini, G;
Dispenzieri, A;
Sanchorawala, V;
Schoenland, SO;
Palladini, G;
Hawkins, PN;
Gertz, MA;
(2018)
Systemic immunoglobulin light chain amyloidosis.
Nature Reviews Disease Primers
, 4
, Article 38. 10.1038/s41572-018-0034-3.
|
Merrill, JT;
Wallace, DJ;
Wax, S;
Kao, A;
Fraser, PA;
Chang, P;
Isenberg, D;
(2018)
Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty‐Four–Week, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Arm, Phase IIb Study.
Arthritis & Rheumatology
, 70
(2)
pp. 266-276.
10.1002/art.40360.
|
Mihai, C;
Antic, M;
Dobrota, R;
Bonderman, D;
Chadha-Boreham, H;
Coghlan, JG;
Denton, CP;
... Distler, O; + view all
(2018)
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort.
Annals of the Rheumatic Diseases
, 77
(1)
pp. 128-132.
10.1136/annrheumdis-2017-211480.
|
Mills, SD;
Kwakkenbos, L;
Carrier, ME;
Gholizadeh, S;
Fox, RS;
Jewett, LR;
Gottesman, K;
... Launay, D; + view all
(2018)
Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.
Arthritis Care and Research
, 70
(10)
pp. 1557-1562.
10.1002/acr.23514.
|
Moreno-Moral, A;
Bagnati, M;
Koturan, S;
Ko, J-H;
Fonseca, C;
Harmston, N;
Game, L;
... Petretto, E; + view all
(2018)
Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk.
Annals of the Rheumatic Diseases
, 77
(4)
pp. 596-601.
10.1136/annrheumdis-2017-212454.
|
Morgan, S;
Lei, L;
Ciurtin, C;
(2018)
Hand ultrasound in systemic lupus erythematosus and Sjögren’s syndrome: a diagnostic and management tool for the assessment of inflammatory arthritis.
Presented at: British Society of Rheumatology Conference, Liverpool, UK.
(In press).
|
Mura, S;
Fin, A;
Parodi, PC;
Denton, CP;
Howell, KJ;
Rampino Cordaro, E;
(2018)
Autologous fat transfer in the successful treatment of upper limb linear morphoea.
[Letter].
Clinical and Experimental Rheumatology
(In press).
|
N
Nanthapisal, S;
Eleftheriou, D;
Gilmour, K;
Leone, V;
Ramnath, R;
Omoyinmi, E;
Hong, Y;
... Brogan, PA; + view all
(2018)
Cutaneous vasculitis and recurrent infection caused by deficiency in complement factor I.
Frontiers in Immunology
, 9
, Article 735. 10.3389/fimmu.2018.00735.
|
Nguyen, DX;
Cotton, A;
Attipoe, L;
Ciurtin, C;
Doré, CJ;
Ehrenstein, MR;
(2018)
Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis.
Journal of Allergy and Clinical Immunology
, 142
(3)
pp. 978-980.
10.1016/j.jaci.2018.04.026.
|
Ntatsaki, E;
Velo-Garcia, A;
Vassiliou, V;
Salama, A;
Isenberg, D;
(2018)
Impact of pre-transplant time on dialysis on survival in patients with lupus nephritis.
Clinical Rheumatology
, 37
(9)
pp. 2399-2404.
10.1007/s10067-018-4115-1.
|
O
Oleinika, K;
Rosser, EC;
Matei, DE;
Nistala, K;
Bosma, A;
Drozdov, I;
Mauri, C;
(2018)
CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells.
Nature Communications
, 9
, Article 684. 10.1038/s41467-018-02911-y.
|
Omoyinmi, E;
Mohamoud, I;
Gilmour, K;
Brogan, PA;
Eleftheriou, D;
(2018)
Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in C3.
Frontiers in Immunology
, 9
, Article 2524. 10.3389/fimmu.2018.02524.
|
Orlandi, M;
Guinto, J;
Bakshi, J;
Cotton, A;
Wilton, J;
Bernstein, B;
D'Aiuto, F;
(2018)
Prevalence of periodontitis in patients with rheumatoid arthritis and systemic lupus erythematosus.
Presented at: British Society for Rheumatology Annual Conference 2018, Liverpool, UK.
|
P
Papaioannou, I;
Xu, S;
Denton, CP;
Abraham, D;
Ponticos, M;
(2018)
STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis post-transcriptionally and is essential for lung myofibroblast differentiation.
Molecular Biology of the Cell
, 29
(2)
pp. 84-95.
10.1091/mbc.E17-06-0342.
|
Parker, MJS;
Oldroyd, A;
Roberts, ME;
Ollier, WE;
New, RP;
Cooper, RG;
Chinoy, H;
... Winer, J; + view all
(2018)
Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: A 10-year epidemiological study.
Rheumatology Advances in Practice
, 2
(2)
, Article rky035. 10.1093/rap/rky035.
|
Parkes, JE;
Rothwell, S;
Oldroyd, A;
Chinoy, H;
Lamb, JA;
Lundberg, IE;
Miller, FW;
... Betteridge, ZE; + view all
(2018)
Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis.
Arthritis Research and Therapy
, 20
, Article 117. 10.1186/s13075-018-1617-9.
|
Pauling, JD;
Frech, TM;
Hughes, M;
Gordon, JK;
Domsic, RT;
Anderson, ME;
Ingegnoli, F;
... Herrick, AL; + view all
(2018)
Patient-reported outcome instruments for assessing Raynaud’s phenomenon in systemic sclerosis: A SCTC vascular working group report.
Journal of Scleroderma and Related Disorders
, 3
(3)
pp. 249-252.
10.1177/2397198318774307.
|
Pepys, MB;
(2018)
The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.
Frontiers in Immunology
, 9
, Article 2382. 10.3389/fimmu.2018.02382.
|
Piper, CJM;
Wilkinson, MGL;
Deakin, CT;
Otto, GW;
Dowle, S;
Duurland, CL;
Adams, S;
... Marques, R; + view all
(2018)
CD19+CD24hiCD38hi B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-α.
Frontiers in Immunology
, 9
, Article 1372. 10.3389/fimmu.2018.01372.
|
Pope, JE;
Lee, JJ;
Denton, CP;
(2018)
Editorial: Bench to Bedside—and Back Again: Finding the Goldilocks Zone Within the Scleroderma Universe.
[Editorial comment].
Arthritis & Rheumatology
, 70
(2)
pp. 155-156.
10.1002/art.40373.
|
Q
Quelhas da Costa, R;
Aguirre-Alastuey, ME;
Isenberg, DA;
Saracino, AM;
(2018)
Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus.
JAMA Dermatology
, 154
(12)
pp. 1432-1440.
10.1001/jamadermatol.2018.3793.
|
R
RA-MAP Consortium, .;
(2018)
Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data.
RMD Open
, 4
(2)
, Article e000721. 10.1136/rmdopen-2018-000721.
|
Rafiq, NK;
Lachmann, H;
Joensen, F;
Herlin, T;
Brogan, PA;
(2018)
Tocilizumab for the Treatment of Mevalonate Kinase Deficiency.
Case Reports in Pediatrics
, 2018
, Article 3514645. 10.1155/2018/3514645.
|
Raine, C;
Canning, B;
Marks, J;
Donnelly, S;
Ong, V;
Tahir, H;
(2018)
Severe gangrene in a patient with anti-RNP positive limited cutaneous systemic sclerosis/rheumatoid arthritis overlap syndrome caused by vasculopathy and vasculitis.
European Journal of Rheumatology
, 5
(4)
pp. 269-271.
10.5152/eurjrheum.2018.17177.
|
Ramirez, G;
Cohen, H;
Mackie, I;
Isenberg, D;
Efthymiou, M;
(2018)
Prevalence of anti-protein C antibodies and acquired activated protein C resistance and in systemic lupus erythematosus.
Presented at: British Society for Haemostasis and Thrombosis, Coventry, UK.
|
Rezk, T;
Gilbertson, JA;
Rowczenio, D;
Bass, P;
Lachmann, HJ;
Wechalekar, AD;
Fontana, M;
... Gillmore, JD; + view all
(2018)
Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis.
Nephrology Dialysis Transplantation
, 33
(2)
pp. 241-247.
10.1093/ndt/gfw375.
|
Richards, DB;
Cookson, LM;
Barton, SV;
Liefaard, L;
Lane, T;
Hutt, DF;
Ritter, JM;
... Pepys, MB; + view all
(2018)
Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis.
Science Translational Medecine
, 10
(422)
, Article eaan3128. 10.1126/scitranslmed.aan3128.
|
Ripoll, VM;
Pregnolato, F;
Mazza, S;
Bodio, C;
Grossi, C;
McDonnell, T;
Pericleous, C;
... Giles, IP; + view all
(2018)
Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome.
Journal of Autoimmunity
10.1016/j.jaut.2018.07.002.
(In press).
|
Robinson, George Anthony;
(2018)
The role of lipid metabolism in the immunopathogenesis of juvenile-onset systemic lupus erythematosus.
Doctoral thesis (Ph.D), UCL (University College London).
|
Rosmini, S;
Bulluck, H;
Captur, G;
Treibel, TA;
Abdel-Gadir, A;
Bhuva, AN;
Culotta, V;
... Moon, JC; + view all
(2018)
Myocardial native T1 and extracellular volume with healthy ageing and gender.
European Heart Journal - Cardiovascular Imaging
, 19
(6)
pp. 615-621.
10.1093/ehjci/jey034.
|
Ross, JC;
Hutt, DF;
Burniston, M;
Page, J;
Steeden, JA;
Gillmore, JD;
Wechalekar, AD;
... Fontana, M; + view all
(2018)
Quantitation of Tc-99m-DPD uptake in patients with transthyretin-related cardiac amyloidosis.
Amyloid
, 25
(3)
pp. 203-210.
10.1080/13506129.2018.1520087.
|
Rosser, EC;
Lom, H;
Bending, D;
Duurland, CL;
Bajaj-Elliott, M;
Wedderburn, LR;
(2018)
Brief Report: Innate lymphoid cells and T-cells contribute to the IL-17A signature detected in the synovial fluid of patients with Juvenile Idiopathic Arthritis.
Arthritis and Rheumatology
10.1002/art.40731.
(In press).
|
S
Sayed, Rabya Hussain;
(2018)
Advances in the Diagnosis and Treatment of Amyloidosis and Related Disorders.
Doctoral thesis (M.D(Res)), UCL (University College London).
|
Scully, PR;
Treibel, TA;
Fontana, M;
Lloyd, G;
Mullen, M;
Pugliese, F;
Hartman, N;
... Moon, JC; + view all
(2018)
Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement.
Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement
, 71
(4)
pp. 463-464.
10.1016/j.jacc.2017.11.037.
|
Sharpley, FA;
Manwani, R;
Mahmood, S;
Sachchithanantham, S;
Lachmann, H;
Gilmore, J;
Whelan, C;
... Wechalekar, A; + view all
(2018)
Real world outcomes of pomalidomide for treatment of relapsed light chain amyloidosis.
British Journal of Haematology
, 183
(4)
pp. 557-563.
10.1111/bjh.15541.
|
Simonneau, G;
Montani, D;
Celermajer, DS;
Denton, CP;
Gatzoulis, MA;
Krowka, M;
Williams, PG;
(2018)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
European Respiratory Journal
10.1183/13993003.01913-2018.
|
Sin, FE;
Isenberg, D;
(2018)
An evaluation of voclosporin for the treatment of lupus nephritis.
Expert Opinion on Pharmacotherapy
, 19
(14)
pp. 1613-1621.
10.1080/14656566.2018.1516751.
|
Singh Sangha, M;
Wright, ML;
Ciurtin, C;
(2018)
Strongly positive anti-CCP antibodies in patients with sacroiliitis or reactive arthritis post-E. coli infection: A mini case-series based review.
International Journal of Rheumatic Diseases
, 21
(1)
pp. 315-321.
10.1111/1756-185X.13113.
|
Sivakumaran, P;
Hussain, S;
Ciurtin, C;
(2018)
Comparison between Several Ultrasound Hand Joint Scores and Conventional Radiography in Diagnosing Hand Osteoarthritis.
Ultrasound in Medicine & Biology
, 44
(3)
pp. 544-550.
10.1016/j.ultrasmedbio.2017.11.009.
|
Stopforth, RJ;
Oldham, RJ;
Tutt, AL;
Duriez, P;
Chan, HTC;
Binkowski, BF;
Zimprich, C;
... Cragg, MS; + view all
(2018)
Detection of Experimental and Clinical Immune Complexes by Measuring SHIP-1 Recruitment to the Inhibitory FcγRIIB.
The Journal of Immunology
, 200
(5)
pp. 1937-1950.
10.4049/jimmunol.1700832.
|
T
Taher, TE;
Ong, VH;
Bystrom, J;
Hillion, S;
Simon, Q;
Denton, CP;
Pers, JO;
... Mageed, RA; + view all
(2018)
Association of Defective Regulation of Autoreactive Interleukin‐6–Producing Transitional B Lymphocytes With Disease in Patients With Systemic Sclerosis.
Arthritis and Rheumatology
, 70
(3)
pp. 450-461.
10.1002/art.40390.
|
Ter Haar, NM;
van Delft, ALJ;
Annink, KV;
van Stel, H;
Al-Mayouf, SM;
Amaryan, G;
Anton, J;
... Frenkel, J; + view all
(2018)
In silico validation of the Autoinflammatory Disease Damage Index.
Annals of the Rheumatic Diseases
, 77
(11)
pp. 1599-1605.
10.1136/annrheumdis-2018-213725.
|
Thompson, N;
Akash, G;
Radmore, R;
Gupta, V;
Robinson, G;
Isenberg, D;
Jury, E;
(2018)
Complex immunophenotyping stratifies patients with primary and secondary Sjögren's syndrome into distinct clinically relevant groups with potential therapeutic implications.
Presented at: British Society for Rheumatology Annual Conference 2018, Liverpool, UK.
|
Thompson, Nicolyn;
(2018)
Complex immunophenotyping stratifies patients with primary and secondary Sjögren’s syndrome into distinct clinically relevant groups with potential therapeutic implications.
Doctoral thesis (Ph.D), UCL (University College London).
|
Treibel, TA;
Kozor, R;
Schofield, R;
Benedetti, G;
Fontana, M;
Bhuva, AN;
Sheikh, A;
... Moon, JC; + view all
(2018)
Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis.
Journal of the American College of Cardiology
, 71
(8)
pp. 860-871.
10.1016/j.jacc.2017.12.035.
|
W
Waddington, Kirsty Elizabeth;
(2018)
Regulation of membrane lipid metabolism and immune cell function by the nuclear receptor LXR.
Doctoral thesis (Ph.D), UCL (University College London).
|
Wagner, T;
Page, J;
Burniston, M;
Skillen, A;
Ross, JC;
Manwani, R;
McCool, D;
... Wechalekar, AD; + view all
(2018)
Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds.
European Journal of Nuclear Medicine and Molecular Imaging
, 45
(7)
pp. 1129-1138.
10.1007/s00259-018-3995-2.
|
Webb, K;
Butler, G;
Ciurtin, C;
Peckham, H;
Radziszewska, A;
Wedderburn, L;
Ioannou, J;
(2018)
Pubertal females produce an enhanced interferon-alpha anti-viral response compared to males, which is associated with X chromosome number, and not sex hormones.
Presented at: 57th European Society of Paediatric Endocrinology Congress (ESPE), Athens, Greece.
|
Webb, K;
Butler, G;
Ciurtin, C;
Peckham, H;
Radziszewska, A;
Wedderburn, L;
Ioannou, J;
(2018)
Sex Differences in Autoimmune Disease: Testosterone is Associated with a Decrease in Expression of Key Anti-viral Genes During Puberty, Which may Decrease the Risk of Autoimmunity in Males.
Presented at: 57th European Society of Paediatric Endocrinology Congress (ESPE), Athens, Greece.
|
Webb, K;
Butler, G;
Ciurtin, C;
Peckham, H;
Radziszewska, A;
Wedderburn, L;
Ioannou, Y;
(2018)
Juvenile systemic lupus erythematosus with a baseline high interferon signature associates with increased immune cell TLR7 expression and enhanced TLR7 dependent IFNα production.
Presented at: 57th European Society of Paediatric Endocrinology Congress (ESPE), Athens, Greece.
|
Wechalekar, AD;
(2018)
Biomarkers in AL amyloidosis: is the summit in sight?
Blood
, 131
(14)
pp. 1502-1503.
10.1182/blood-2018-02-832113.
|
Wilkinson, JD;
Leggett, SA;
Marjanovic, EJ;
Moore, TL;
Allen, J;
Anderson, ME;
Britton, J;
... Murray, AK; + view all
(2018)
A multicentre study of validity and reliability of responses to hand cold challenge as measured by laser speckle contrast imaging and thermography: outcome measures for systemic sclerosis-related Raynaud's phenomenon.
Arthritis Rheumatology
, 70
(6)
pp. 903-911.
10.1002/art.40457.
|
Wilkinson, Meredyth Grace Llewellyn;
(2018)
Investigating novel pathways in B cell mediated autoimmunity in the context of the disease juvenile dermatomyositis.
Doctoral thesis (Ph.D), UCL (University College London).
|
Wong, SW;
Hegenbart, U;
Palladini, G;
Shah, GL;
Landau, HJ;
Warner, M;
Toskic, D;
... Comenzo, RL; + view all
(2018)
Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p.
Clinical Lymphoma, Myeloma and Leukemia
, 18
(11)
e493-e499.
10.1016/j.clml.2018.07.292.
|
Y
Yeoh, SA;
Dias, SS;
Isenberg, DA;
(2018)
Advances in systemic lupus erythematosus.
Medicine
, 46
(2)
pp. 84-92.
10.1016/j.mpmed.2017.11.010.
|
Youngstein, T;
B C Koh, M;
Ros Soto, J;
Rowczenio, D;
Trojer, H;
Lachmann, HJ;
Sofat, N;
(2018)
Adult-onset tumour necrosis factor receptor-associated periodic syndrome presenting as transfusion-dependent refractory haemophagocytosis.
Rheumatology
, 57
(3)
pp. 582-583.
10.1093/rheumatology/kex427.
|
Z
Zumbo, G;
Barton, SV;
Thompson, D;
Sun, M;
Abdel-Gadir, A;
Treibel, TA;
Knight, D;
... Fontana, M; + view all
(2018)
Extracellular volume with bolus-only technique in amyloidosis patients: Diagnostic accuracy, correlation with other clinical cardiac measures, and ability to track changes in amyloid load over time.
Journal of Magnetic Resonance Imaging
, 47
(6)
pp. 1677-1684.
10.1002/jmri.25907.
|